RALEIGH, N.C., April 17 /PRNewswire/ -- CLOSURE Medical Corporation
(Nasdaq: CLSR), a medical tissue adhesive products company, today announced
that it intends to release, on Tuesday, April 24, 2001, financial results for
the first quarter ended March 31, 2001. In conjunction with this release
CLOSURE will host a conference call that will be broadcast simultaneously live
over the Internet.
Individuals wishing to participate on the webcast, to be held at 4:30 PM
EST on Tuesday, April 24, 2001, can access the event at http://www.vcall.com .
Please allow extra time prior to the call to download the streaming media
software required for listening to the Internet broadcast. The online archive
of the broadcast will be available within 2 hours of the live call and will be
available for replay for 90 days.
CLOSURE Medical Corporation, headquartered in Raleigh, North Carolina,
develops, manufactures, and commercializes medical tissue adhesive products
based on its proprietary cyanoacrylate technology. CLOSURE's nonabsorbable
tissue adhesive products may be used to replace sutures and staples for
certain topical wound closure applications, while its internal tissue adhesive
products can potentially be used for internal wound closure and management.
Currently marketed nonabsorbable tissue adhesive products include:
DERMABOND(R) Topical Skin Adhesive, which is used to replace sutures and
staples for closure of certain lacerations and incisions; SOOTHE-N-SEAL(TM)
canker sore relief, an over-the-counter product to treat oral ulcers and mouth
sores; and NEXABAND(R) topical adhesives used in veterinary wound closure and
management. The Company's LIQUIDERM(TM) liquid adhesive bandage has been
approved by the FDA for the over-the-counter adhesive bandage market.
DERMABOND(R) adhesive is a registered trademark of Ethicon, Inc.;
SOOTHE-N-SEAL(TM) canker sore relief is a licensed trademark of Colgate Oral
Pharmaceuticals, Inc.; LIQUIDERM(TM) adhesive is a trademark of CLOSURE
Medical Corporation; and NEXABAND(R) adhesive is a registered trademark of
CLOSURE Medical Corporation.
To receive CLOSURE's latest news release and other corporate documents via
fax, at no cost, call 1-800-PRO-INFO, use the Company's symbol CLSR. Or visit
the Financial Relations Board's website at http://www.frbinc.com .
This release contains certain forward-looking statements which involve
known and unknown risks, delays, uncertainties or other factors not under the
Company's control which may cause actual results, performance or achievements
of the Company to be materially different from the results, performance, or
other expectations implied by these forward-looking statements. These factors
include, but are not limited to the early stage of commercialization of the
Company products; the progress of its research and development programs for
future products; the need for regulatory approval and effects of governmental
regulation; technological uncertainties; the satisfactory conclusion of
negotiations with, and dependence on marketing partners, and dependence on
patents and trade secrets, as well as those detailed in the Company's Annual
Report on Form 10-K for the year ended December 31, 2000 filed with the
Securities and Exchange Commission.
SOURCE CLOSURE Medical Corporation
 back to top
Related links:
http://www.frbinc.com
CONTACT:
Robert V. Toni, President & CEO, or Benny
Ward, CFO, 919-876-7800, both of CLOSURE Medical Corporation; or
General Info, Paula Schwartz, Analysts, Julie Tu, Media, Judith
Sylk-Siegel, 212-661-8030, of The Financial Relations Board BSMG
Worldwide
|
